These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 2824900)
41. [In suspected bronchial cancer are the tumor markers neuron-specific enolase, carcinoembryonic antigen and squamous cell carcinoma antigen, of diagnostic help?]. Jany B; Fischbach W; Chowanetz W Med Klin (Munich); 1988 Feb; 83(4):121-4, 158. PubMed ID: 3367874 [No Abstract] [Full Text] [Related]
42. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels]. Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919 [TBL] [Abstract][Full Text] [Related]
43. [Neuron-specific enolase as a tumor marker]. Biran H Harefuah; 1994 Dec; 127(11):500-2. PubMed ID: 7806116 [No Abstract] [Full Text] [Related]
44. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE]. Prévost A; Passemard F; Perdu D; Vallerand H; Deschamps F; Lavaud F; Larbre H Rev Mal Respir; 1994; 11(4):379-84. PubMed ID: 7973038 [TBL] [Abstract][Full Text] [Related]
45. [Tumor markers in lung cancer]. Niho S; Shinkai T Gan To Kagaku Ryoho; 2001 Dec; 28(13):2089-93. PubMed ID: 11791391 [TBL] [Abstract][Full Text] [Related]
46. Immunodetection of neuron-specific enolase and keratin in cytological preparations as an aid in the differential diagnosis of lung cancer. Kyrkou KA; Iatridis SG; Athanassiadou PP; Lambropoulou S; Liossi A Diagn Cytopathol; 1986 Sep; 2(3):217-20. PubMed ID: 2429809 [TBL] [Abstract][Full Text] [Related]
47. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma. Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072 [TBL] [Abstract][Full Text] [Related]
49. [A clinical evaluation of the versatility of various tumor markers in diagnosing the primary carcinoma of the lung]. Shimabukuro Z Nihon Ika Daigaku Zasshi; 1989 Jun; 56(3):281-93. PubMed ID: 2546967 [TBL] [Abstract][Full Text] [Related]
50. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay. Muley T; Ebert W; Stieber P; Raith H; Holdenrieder S; Nagel D; Fürst H; Roth HJ; Luthe H; Blijenberg BG; Gurr E; Uhl W; von Pawel J; Drings P Clin Chem Lab Med; 2003 Jan; 41(1):95-103. PubMed ID: 12636057 [TBL] [Abstract][Full Text] [Related]
51. Neuron specific enolase: a marker of (small cell) cancers of neuronal and neuroendocrine origin. Cooper EH Biomed Pharmacother; 1985; 39(4):165-6. PubMed ID: 2998499 [TBL] [Abstract][Full Text] [Related]
52. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076 [TBL] [Abstract][Full Text] [Related]
53. [Determination of serum neuron-specific enolase in bronchial tumors of neuroendocrine origin]. Rapellino M; Pecchio F; Cunazza M; Baldi S; Adamo MR; Casadio C; Faga C; Baldi C; Oliaro A; Albertino B Minerva Med; 1988 Dec; 79(12):1051-2. PubMed ID: 2850512 [TBL] [Abstract][Full Text] [Related]
54. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)]. Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253 [TBL] [Abstract][Full Text] [Related]
55. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer. Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381 [TBL] [Abstract][Full Text] [Related]
56. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung. Johnson DH; Marangos PJ; Forbes JT; Hainsworth JD; Van Welch R; Hande KR; Greco FA Cancer Res; 1984 Nov; 44(11):5409-14. PubMed ID: 6091878 [TBL] [Abstract][Full Text] [Related]
57. Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase. Schmitt UM; Stieber P; Hasholzner U; Pahl H; Hofmann K; Fateh-Moghadam A Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):679-82. PubMed ID: 8877347 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Miédougé M; Rouzaud P; Salama G; Pujazon MC; Vincent C; Mauduyt MA; Reyre J; Carles P; Serre G Br J Cancer; 1999 Nov; 81(6):1059-65. PubMed ID: 10576665 [TBL] [Abstract][Full Text] [Related]
59. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer]. Yang J; Li R; Li A Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234 [TBL] [Abstract][Full Text] [Related]
60. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer]. Pan QR; Zhang X; Xu ZF; Zheng S Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]